- Home
- WDS vs TEVA Comparison
WDS vs TEVA Comparison
Compare WDS & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDS
- TEVA
- Stock Information
- Founded
- WDS 1954
- TEVA 1901
- Country
- WDS Australia
- TEVA Israel
- Employees
- WDS N/A
- TEVA N/A
- Industry
- WDS Oil & Gas Production
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- WDS Energy
- TEVA Health Care
- Exchange
- WDS Nasdaq
- TEVA Nasdaq
- Market Cap
- WDS 28.4B
- TEVA 21.2B
- IPO Year
- WDS N/A
- TEVA N/A
- Fundamental
- Price
- WDS $16.89
- TEVA $24.02
- Analyst Decision
- WDS Hold
- TEVA Strong Buy
- Analyst Count
- WDS 1
- TEVA 7
- Target Price
- WDS N/A
- TEVA $25.86
- AVG Volume (30 Days)
- WDS 702.2K
- TEVA 12.0M
- Earning Date
- WDS 08-18-2025
- TEVA 11-05-2025
- Dividend Yield
- WDS 6.04%
- TEVA N/A
- EPS Growth
- WDS 58.72
- TEVA N/A
- EPS
- WDS 1.54
- TEVA 0.62
- Revenue
- WDS $13,781,000,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- WDS N/A
- TEVA $4.11
- Revenue Next Year
- WDS N/A
- TEVA $0.40
- P/E Ratio
- WDS $10.78
- TEVA $39.64
- Revenue Growth
- WDS 9.53
- TEVA 0.02
- 52 Week Low
- WDS $11.26
- TEVA $12.47
- 52 Week High
- WDS $17.70
- TEVA $25.00
- Technical
- Relative Strength Index (RSI)
- WDS 71.10
- TEVA 76.02
- Support Level
- WDS $16.07
- TEVA $20.11
- Resistance Level
- WDS $16.39
- TEVA $25.00
- Average True Range (ATR)
- WDS 0.19
- TEVA 0.70
- MACD
- WDS 0.17
- TEVA 0.50
- Stochastic Oscillator
- WDS 99.49
- TEVA 83.00
About WDS Woodside Energy Group Limited
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.